HIPK2 and neoplasm: IHC analysis of C-terminal HIPK2 expression showed negative staining (–) in 50% of 64 tumor samples, weak staining (+) in 39.1%, moderate staining (++) in 9.4%, and strong staining (+++) in 1.6% (Figure 2A and 2B).